Clinical Trial Update: Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of fluticasone furoate inhalation powder on the hypothalamic-pituitary-adrenal axis in children aged 5-11 with asthma; compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• fluticasone furoate inhalation powder (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2017-03-08